A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor

NCT05021367 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: TQB3823 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.